Literature DB >> 19429886

Measures of postprandial lipoproteins are not associated with coronary artery disease in patients with type 2 diabetes mellitus.

Gissette Reyes-Soffer1, Steve Holleran, Wahida Karmally, Colleen I Ngai, Niem-Tzu Chen, Margarita Torres, Rajasekhar Ramakrishnan, William S Blaner, Lars Berglund, Henry N Ginsberg, Catherine Tuck.   

Abstract

Individuals with type 2 diabetes mellitus (DM) characteristically have elevated fasting and postprandial (PP) plasma triglycerides (TG). Previous case-control studies indicated that PPTG levels predict the presence of coronary artery disease (CAD) in people without DM; however, the data for patients with DM are conflicting. Therefore, we conducted a case-control study in DM individuals, 84 with (+) and 80 without (-) CAD. Our hypothesis was that DM individuals with or without CAD would have similar PPTG levels, but CAD+ individuals would have more small d<1.006 g/L lipoprotein particles. Several markers of PP lipid metabolism were measured over 10 h after a fat load. PP lipoprotein size and particle number were also determined. There was no significant difference in any measure of PP lipid metabolism between CAD+ and CAD-, except for apoB48, which was actually higher in CAD-. We followed 69 CAD- participants for a mean 8.7 years; 33 remained free of any cardiovascular event. There were no PP differences at baseline between these 33 who remained CAD- and either the 36 original CAD- who subsequently developed CAD or the original CAD+ group.PP measurements of TG-rich lipoproteins do not predict the presence of CAD in individuals with DM.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19429886      PMCID: PMC2724776          DOI: 10.1194/jlr.M900092-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  39 in total

Review 1.  Measurement of triglyceride-rich lipoproteins by nuclear magnetic resonance spectroscopy.

Authors:  J Otvos
Journal:  Clin Cardiol       Date:  1999-06       Impact factor: 2.882

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

3.  Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease.

Authors:  N Mero; R Malmström; G Steiner; M R Taskinen; M Syvänne
Journal:  Atherosclerosis       Date:  2000-05       Impact factor: 5.162

4.  Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70% stenotic coronary artery disease: a case-control study.

Authors:  E Meyer; H T Westerveld; F C de Ruyter-Meijstek; M M van Greevenbroek; R Rienks; H J van Rijn; D W Erkelens; T W de Bruin
Journal:  Atherosclerosis       Date:  1996-08-02       Impact factor: 5.162

5.  Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.

Authors:  J E Hokanson; M A Austin
Journal:  J Cardiovasc Risk       Date:  1996-04

6.  Low-density lipoprotein subclass patterns and risk of myocardial infarction.

Authors:  M A Austin; J L Breslow; C H Hennekens; J E Buring; W C Willett; R M Krauss
Journal:  JAMA       Date:  1988-10-07       Impact factor: 56.272

7.  Plasma apolipoprotein changes in the triglyceride-rich lipoprotein fraction of human subjects fed a fat-rich meal.

Authors:  J S Cohn; J R McNamara; S D Cohn; J M Ordovas; E J Schaefer
Journal:  J Lipid Res       Date:  1988-07       Impact factor: 5.922

8.  Association of postprandial triglyceride and retinyl palmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle-aged men and women.

Authors:  H N Ginsberg; J Jones; W S Blaner; A Thomas; W Karmally; L Fields; D Blood; M D Begg
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-11       Impact factor: 8.311

Review 9.  Metabolic abnormalities: triglyceride and low-density lipoprotein.

Authors:  Ronald M Krauss; Patty W Siri
Journal:  Endocrinol Metab Clin North Am       Date:  2004-06       Impact factor: 4.741

10.  Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner media.

Authors:  B G Nordestgaard; R Wootton; B Lewis
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-04       Impact factor: 8.311

View more
  11 in total

Review 1.  Peripheral arterial disease, type 2 diabetes and postprandial lipidaemia: Is there a link?

Authors:  Pedro Valdivielso; José Ramírez-Bollero; Carmen Pérez-López
Journal:  World J Diabetes       Date:  2014-10-15

2.  Low density lipoprotein delays clearance of triglyceride-rich lipoprotein by human subcutaneous adipose tissue.

Authors:  Simon Bissonnette; Huda Salem; Hanny Wassef; Nathalie Saint-Pierre; Annie Tardif; Alexis Baass; Robert Dufour; May Faraj
Journal:  J Lipid Res       Date:  2013-02-17       Impact factor: 5.922

3.  Postprandial lipoproteins and cardiovascular disease risk in diabetes mellitus.

Authors:  Byambaa Enkhmaa; Zeynep Ozturk; Erdembileg Anuurad; Lars Berglund
Journal:  Curr Diab Rep       Date:  2010-02       Impact factor: 4.810

4.  Effects of mipomersen, an apolipoprotein B100 antisense, on lipoprotein (a) metabolism in healthy subjects.

Authors:  Renu Nandakumar; Anastasiya Matveyenko; Tiffany Thomas; Marianna Pavlyha; Colleen Ngai; Stephen Holleran; Rajasekhar Ramakrishnan; Henry N Ginsberg; Wahida Karmally; Santica M Marcovina; Gissette Reyes-Soffer
Journal:  J Lipid Res       Date:  2018-10-07       Impact factor: 5.922

5.  Endothelial function in individuals with coronary artery disease with and without type 2 diabetes mellitus.

Authors:  Gissette Reyes-Soffer; Steve Holleran; Marco R Di Tullio; Shunichi Homma; Bernadette Boden-Albala; Rajasekhar Ramakrishnan; Mitchell S Elkind; Ralph L Sacco; Henry N Ginsberg
Journal:  Metabolism       Date:  2010-01-27       Impact factor: 8.694

6.  Postprandial lipemia and the risk of coronary heart disease and stroke: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Dmitry Kats; A Richey Sharrett; Henry N Ginsberg; Vijay Nambi; Christie M Ballantyne; Ron C Hoogeveen; Gerardo Heiss
Journal:  BMJ Open Diabetes Res Care       Date:  2017-02-01

7.  Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans.

Authors:  Gissette Reyes-Soffer; Marianna Pavlyha; Colleen Ngai; Tiffany Thomas; Stephen Holleran; Rajasekhar Ramakrishnan; Wahida Karmally; Renu Nandakumar; Nelson Fontanez; Joseph Obunike; Santica M Marcovina; Alice H Lichtenstein; Nirupa R Matthan; James Matta; Magali Maroccia; Frederic Becue; Franck Poitiers; Brian Swanson; Lisa Cowan; William J Sasiela; Howard K Surks; Henry N Ginsberg
Journal:  Circulation       Date:  2016-12-16       Impact factor: 29.690

8.  Effect of combination therapy with fenofibrate and simvastatin on postprandial lipemia in the ACCORD lipid trial.

Authors:  Gissette Reyes-Soffer; Colleen I Ngai; Laura Lovato; Wahida Karmally; Rajasekhar Ramakrishnan; Stephen Holleran; Henry N Ginsberg
Journal:  Diabetes Care       Date:  2012-10-01       Impact factor: 19.112

Review 9.  Cardiovascular disease in diabetes, beyond glucose.

Authors:  Robert H Eckel; Karin E Bornfeldt; Ira J Goldberg
Journal:  Cell Metab       Date:  2021-07-21       Impact factor: 31.373

10.  Fasting and postprandial lipid parameters: A comparative evaluation of cardiovascular risk assessment in prediabetes and diabetes.

Authors:  Montosh Chakraborty; Prerna Singh; Jyothi M P Dsouza; Karthikeyan Pethusamy; Pandurang V Thatkar
Journal:  J Family Med Prim Care       Date:  2020-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.